Clinical Trials in Baltimore

Showing 13221-13240 of 20,142 trials

A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC

NCT00882583

Primary Objective for Phase I 1. To determine the maximally tolerated dose (MTD) of daily Oral dasatinib in combination with cetuximab/RT in Cohort A. 2. To determine the MTD of daily oral dasatinib in combination with cisplatin/cetuximab/RT in Cohort B

Head and Neck Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins22 participantsStarted Jul 2009

Baltimore, Maryland, United States • Columbus, Ohio, United States

COMPLETEDPhase 2< 1 mile

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

NCT00087126

RATIONALE: Drugs used in chemotherapy, such as topotecan, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well topotecan works in treating women with persistent or recurrent cervical cancer.

Cervical Cancer

Gynecologic Oncology Group27 participantsStarted Feb 2005

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +24 more locations

A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

Find Trials by Condition in Baltimore

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]

Digital Tools for Coping With Chronic Pain

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

A Study in Adult Subjects With Select Advanced Solid Tumors

Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

JKB-121 for the Treatment of Nonalcoholic Steatohepatitis

Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study

Evaluation of Vestibular Stimulation to Help Occasional Sleeplessness

Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients

Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)